Comments | Number of participants |
---|---|
Positive response | |
Increased energy | 4/17 |
Reduced fatigue | 1/17 |
More alert | 1/17 |
Aided recovery from mild illness | 1/17 |
Reduced muscle soreness | 1/17 |
Initial improvement | 1/17 |
Minor change | 1/17 |
Negative response | |
No change | 4/17 |
GIT symptoms (flatulence) | 1/17 |
Fatigue not improved | 1/17 |